Pharmaceutical Regulatory Affairs in Chile

The regulatory structure your pharmaceutical portfolio needs in Chile.

SERTURNER helps international pharmaceutical companies assess dossiers, organize portfolios and build a fit-for-purpose local regulatory structure—with senior direction, clear responsibilities and continuity beyond submission.

ISP pharmaceutical submission supportCTD dossier reviewChile Ministry of Health pathway mapping
What we do

Three regulatory pillars.
One coherent Chile structure.

Each engagement starts from the regulatory need. The delivery model then adapts to one dossier, a portfolio or an ongoing operating requirement.

How we deliver

A structure designed around the decision.

DBD, ENTRY Chile and OPERATE are delivery modes—not separate promises. The regulatory pillar defines what must be solved.

DBD

Defined dossier work

One or a few products, with bounded deliverables, review cycles and milestones.

Best fit
Clearly identified products and dossier work.
ENTRY Chile

Portfolio execution

A prioritized portfolio advanced in agreed waves from a common baseline.

Best fit
Several products requiring sequencing and shared governance.
OPERATE

Regulatory continuity

A configurable service catalogue for a defined inventory, period and capacity.

Best fit
Ongoing lifecycle responsibilities after the initial scope.
BALinkedIn ↗
Founder-led

Senior regulatory direction stays close to the work.

Boris Araya Ibarra leads critical regulatory decisions, the primary client relationship and final review of work delivered under SERTURNER's responsibility.

About SERTURNER →Connect with Boris on LinkedIn ↗
Published by SERTURNER

Dose Dumping

Pharmaceutical industry intelligence for decision-makers: Chilean market developments in Spanish and regulatory guidance for international teams in English.

Chile, made workable

Define the next controlled step.

Share a non-confidential overview of your products, dossier baseline and intended local structure.

Start a conversation